Abivax S.A. (ABVX)

R&D Expenses

€58.34M

Quarterly · Period ending: · EUR

ABVX logo

ABVX R&D Expenses

Latest reported€58.34M EUR
ABVX Quarterly R&D Expenses · EUR (€0.00 → €58.34M)
High-resolution chart · PNG

ABVX r&d expenses history

Quarterly · EUR. Dates are reporting period ends; fiscal years can differ from calendar years.

Abivax S.A. R&D Expenses — Quarterly (EUR)
Period endingR&D Expenses (EUR)
58,335,000
44,399,000
38,645,000
39,301,000
28,907,000
70,554,000
32,622,000
32,839,000
15,107,000
23,247,000
23,955,000
21,058,000
13,468,000
14,026,000
14,981,000
8,807,000
7,061,000
5,117,000
5,729,000
6,254,000
9,205,000
8,308,000
6,959,000
3,764,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.